Mario Santiago
Concepts (385)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Friend murine leukemia virus | 17 | 2021 | 30 | 6.720 |
Why?
| Retroviridae Infections | 20 | 2021 | 46 | 5.850 |
Why?
| Cytidine Deaminase | 20 | 2018 | 58 | 5.650 |
Why?
| HIV-1 | 28 | 2022 | 783 | 3.370 |
Why?
| Antibodies, Neutralizing | 10 | 2022 | 229 | 2.790 |
Why?
| Virus Replication | 17 | 2020 | 409 | 2.590 |
Why?
| Simian Immunodeficiency Virus | 19 | 2015 | 86 | 2.130 |
Why?
| Antiviral Agents | 9 | 2022 | 670 | 2.070 |
Why?
| Interferon-alpha | 7 | 2020 | 190 | 2.070 |
Why?
| Antibodies, Viral | 12 | 2022 | 551 | 2.010 |
Why?
| HIV Infections | 20 | 2023 | 2532 | 1.960 |
Why?
| Somatic Hypermutation, Immunoglobulin | 3 | 2022 | 18 | 1.900 |
Why?
| Simian Acquired Immunodeficiency Syndrome | 11 | 2015 | 85 | 1.770 |
Why?
| Antigens, CD | 5 | 2016 | 506 | 1.680 |
Why?
| Tumor Virus Infections | 7 | 2014 | 41 | 1.570 |
Why?
| Dendritic Cells | 5 | 2020 | 445 | 1.540 |
Why?
| Gastrointestinal Tract | 3 | 2022 | 176 | 1.510 |
Why?
| Adaptive Immunity | 3 | 2021 | 165 | 1.330 |
Why?
| Immunity, Innate | 11 | 2021 | 762 | 1.280 |
Why?
| Membrane Glycoproteins | 3 | 2016 | 462 | 1.230 |
Why?
| Interferon Type I | 7 | 2022 | 134 | 1.210 |
Why?
| CD4-Positive T-Lymphocytes | 11 | 2022 | 1003 | 1.070 |
Why?
| Pan troglodytes | 11 | 2009 | 57 | 1.010 |
Why?
| SAM Domain and HD Domain-Containing Protein 1 | 2 | 2021 | 4 | 1.010 |
Why?
| Interferons | 2 | 2022 | 154 | 1.000 |
Why?
| Immunoglobulin A | 2 | 2022 | 179 | 0.840 |
Why?
| Mice, Inbred BALB C | 10 | 2021 | 1245 | 0.820 |
Why?
| Interferon-beta | 2 | 2020 | 87 | 0.790 |
Why?
| Mice, Knockout | 12 | 2021 | 2737 | 0.780 |
Why?
| Animals | 60 | 2023 | 34133 | 0.780 |
Why?
| Viral Load | 9 | 2021 | 423 | 0.750 |
Why?
| CD8-Positive T-Lymphocytes | 8 | 2021 | 715 | 0.730 |
Why?
| Virion | 4 | 2016 | 78 | 0.710 |
Why?
| B-Lymphocytes | 6 | 2023 | 936 | 0.710 |
Why?
| Proteins | 6 | 2022 | 953 | 0.680 |
Why?
| Killer Cells, Natural | 5 | 2016 | 386 | 0.680 |
Why?
| Mice | 26 | 2023 | 15888 | 0.670 |
Why?
| Leukemia, Experimental | 4 | 2014 | 28 | 0.660 |
Why?
| Lipopolysaccharides | 1 | 2021 | 875 | 0.640 |
Why?
| Mice, Inbred C57BL | 15 | 2021 | 5020 | 0.620 |
Why?
| Enterobacteriaceae | 1 | 2017 | 33 | 0.600 |
Why?
| RNA, Viral | 8 | 2016 | 597 | 0.560 |
Why?
| Immunity, Cellular | 2 | 2016 | 276 | 0.550 |
Why?
| Host-Pathogen Interactions | 4 | 2020 | 313 | 0.550 |
Why?
| Immunoglobulin Variable Region | 1 | 2015 | 73 | 0.520 |
Why?
| Immunoglobulin Heavy Chains | 1 | 2015 | 75 | 0.520 |
Why?
| Feces | 10 | 2017 | 410 | 0.520 |
Why?
| Immunomodulation | 1 | 2016 | 91 | 0.520 |
Why?
| Immunoglobulin Fc Fragments | 1 | 2015 | 35 | 0.510 |
Why?
| Dysbiosis | 4 | 2022 | 148 | 0.500 |
Why?
| Viremia | 6 | 2020 | 133 | 0.500 |
Why?
| Intestines | 1 | 2017 | 338 | 0.470 |
Why?
| Endoribonucleases | 1 | 2013 | 73 | 0.440 |
Why?
| Antibody Formation | 3 | 2017 | 285 | 0.440 |
Why?
| Endogenous Retroviruses | 1 | 2012 | 19 | 0.420 |
Why?
| Molecular Sequence Data | 15 | 2014 | 2933 | 0.390 |
Why?
| Signal Transduction | 5 | 2020 | 4902 | 0.380 |
Why?
| Colon | 4 | 2022 | 241 | 0.380 |
Why?
| Antibody Affinity | 1 | 2010 | 55 | 0.380 |
Why?
| Spleen | 5 | 2018 | 543 | 0.360 |
Why?
| HIV Seropositivity | 2 | 2022 | 117 | 0.360 |
Why?
| Retroviridae | 3 | 2023 | 91 | 0.360 |
Why?
| Intestinal Mucosa | 4 | 2019 | 543 | 0.360 |
Why?
| Antigens, Helminth | 2 | 1999 | 16 | 0.360 |
Why?
| Cercocebus atys | 3 | 2006 | 12 | 0.350 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 1003 | 0.350 |
Why?
| HIV-2 | 3 | 2006 | 15 | 0.340 |
Why?
| Schistosomiasis japonica | 2 | 1999 | 37 | 0.340 |
Why?
| Receptor, Interferon alpha-beta | 2 | 2020 | 23 | 0.340 |
Why?
| Macaca mulatta | 5 | 2021 | 145 | 0.330 |
Why?
| Animals, Wild | 3 | 2005 | 55 | 0.330 |
Why?
| Interleukin-15 | 2 | 2021 | 77 | 0.330 |
Why?
| Base Sequence | 7 | 2015 | 2186 | 0.330 |
Why?
| Lymphocytes | 2 | 2021 | 360 | 0.330 |
Why?
| Humans | 56 | 2022 | 122796 | 0.320 |
Why?
| Cells, Cultured | 10 | 2018 | 4162 | 0.320 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2016 | 2127 | 0.320 |
Why?
| Lymphocyte Activation | 5 | 2017 | 1148 | 0.320 |
Why?
| Antigen Presentation | 2 | 2021 | 198 | 0.320 |
Why?
| Reverse Transcription | 2 | 2021 | 19 | 0.310 |
Why?
| Ape Diseases | 3 | 2008 | 7 | 0.310 |
Why?
| Immunity, Humoral | 2 | 2022 | 116 | 0.310 |
Why?
| Disease Reservoirs | 2 | 2006 | 24 | 0.300 |
Why?
| Flow Cytometry | 4 | 2017 | 1128 | 0.300 |
Why?
| Papillomavirus Infections | 2 | 2022 | 267 | 0.290 |
Why?
| Gastrointestinal Microbiome | 4 | 2022 | 561 | 0.290 |
Why?
| Immunity, Mucosal | 3 | 2020 | 86 | 0.290 |
Why?
| Sequence Analysis, DNA | 5 | 2017 | 766 | 0.280 |
Why?
| Gene Expression Profiling | 5 | 2020 | 1625 | 0.270 |
Why?
| Virus Diseases | 2 | 2018 | 201 | 0.260 |
Why?
| Phylogeny | 13 | 2017 | 830 | 0.260 |
Why?
| Immunoglobulin G | 4 | 2022 | 804 | 0.260 |
Why?
| Disease Models, Animal | 5 | 2018 | 3799 | 0.260 |
Why?
| Genetic Variation | 4 | 2015 | 952 | 0.260 |
Why?
| Granzymes | 2 | 2022 | 40 | 0.250 |
Why?
| Spike Glycoprotein, Coronavirus | 2 | 2022 | 98 | 0.250 |
Why?
| Bone Marrow Cells | 3 | 2016 | 282 | 0.250 |
Why?
| Interferon-gamma | 2 | 2019 | 747 | 0.250 |
Why?
| Cercopithecus | 1 | 2003 | 2 | 0.240 |
Why?
| Immunoglobulin M | 4 | 2022 | 288 | 0.240 |
Why?
| Transcriptome | 2 | 2022 | 774 | 0.240 |
Why?
| DNA, Viral | 3 | 2021 | 358 | 0.230 |
Why?
| NF-kappa B | 2 | 2018 | 676 | 0.230 |
Why?
| Antibodies, Helminth | 2 | 1999 | 11 | 0.220 |
Why?
| Recombination, Genetic | 4 | 2015 | 175 | 0.220 |
Why?
| Genome, Viral | 1 | 2003 | 125 | 0.210 |
Why?
| Viral Regulatory and Accessory Proteins | 2 | 2016 | 27 | 0.210 |
Why?
| Blood | 1 | 2022 | 100 | 0.210 |
Why?
| Ruminococcus | 1 | 2021 | 9 | 0.200 |
Why?
| Acinetobacter | 1 | 2021 | 14 | 0.200 |
Why?
| Lymphopenia | 1 | 2021 | 49 | 0.200 |
Why?
| Acute Disease | 2 | 2016 | 984 | 0.200 |
Why?
| Peripheral Tolerance | 2 | 2020 | 14 | 0.200 |
Why?
| T-Lymphocytes, Helper-Inducer | 2 | 2023 | 133 | 0.200 |
Why?
| Male | 21 | 2021 | 59639 | 0.200 |
Why?
| Evolution, Molecular | 3 | 2016 | 459 | 0.190 |
Why?
| Specimen Handling | 1 | 2022 | 169 | 0.190 |
Why?
| Bacterial Translocation | 2 | 2019 | 37 | 0.190 |
Why?
| Interferon-Induced Helicase, IFIH1 | 1 | 2020 | 14 | 0.190 |
Why?
| Picornaviridae | 1 | 2020 | 18 | 0.180 |
Why?
| Tropomyosin | 1 | 1999 | 13 | 0.180 |
Why?
| Female | 22 | 2021 | 63629 | 0.180 |
Why?
| Immunologic Factors | 2 | 2019 | 228 | 0.180 |
Why?
| Salmonella typhimurium | 1 | 2021 | 179 | 0.180 |
Why?
| Sialic Acid Binding Ig-like Lectin 1 | 1 | 2018 | 1 | 0.170 |
Why?
| nef Gene Products, Human Immunodeficiency Virus | 3 | 2016 | 19 | 0.170 |
Why?
| GPI-Linked Proteins | 2 | 2016 | 57 | 0.170 |
Why?
| Interleukin-2 | 2 | 2022 | 420 | 0.170 |
Why?
| Immunologic Memory | 1 | 2021 | 321 | 0.170 |
Why?
| Helminth Proteins | 1 | 1999 | 21 | 0.170 |
Why?
| Keratinocytes | 2 | 2018 | 238 | 0.170 |
Why?
| Cell Line | 6 | 2020 | 2785 | 0.170 |
Why?
| Gram-Positive Bacteria | 1 | 2019 | 48 | 0.170 |
Why?
| Lymph Nodes | 3 | 2018 | 466 | 0.170 |
Why?
| Genotype | 3 | 2013 | 1943 | 0.170 |
Why?
| Lectins | 1 | 2018 | 52 | 0.170 |
Why?
| Gram-Negative Bacteria | 1 | 2019 | 72 | 0.170 |
Why?
| Protective Agents | 1 | 2018 | 42 | 0.170 |
Why?
| Sexually Transmitted Diseases, Viral | 1 | 1998 | 7 | 0.170 |
Why?
| Papillomavirus E7 Proteins | 1 | 2018 | 10 | 0.160 |
Why?
| Proteome | 1 | 2022 | 357 | 0.160 |
Why?
| Cullin Proteins | 1 | 2018 | 12 | 0.160 |
Why?
| T-Lymphocytes, Cytotoxic | 2 | 2018 | 160 | 0.160 |
Why?
| Human papillomavirus 16 | 1 | 2018 | 25 | 0.160 |
Why?
| HIV | 3 | 2018 | 219 | 0.160 |
Why?
| Human Immunodeficiency Virus Proteins | 2 | 2016 | 6 | 0.160 |
Why?
| APOBEC-1 Deaminase | 2 | 2014 | 5 | 0.160 |
Why?
| Viral Tropism | 1 | 2017 | 24 | 0.150 |
Why?
| Proteolysis | 1 | 2018 | 149 | 0.150 |
Why?
| Interleukins | 1 | 2019 | 246 | 0.150 |
Why?
| Immunoglobulin E | 1 | 1999 | 368 | 0.150 |
Why?
| Parvoviridae Infections | 1 | 2016 | 11 | 0.150 |
Why?
| Toll-Like Receptor 7 | 1 | 2016 | 37 | 0.150 |
Why?
| Allergens | 1 | 2020 | 421 | 0.150 |
Why?
| Mutagenesis, Insertional | 1 | 2016 | 62 | 0.140 |
Why?
| Disease Resistance | 1 | 2016 | 29 | 0.140 |
Why?
| Biological Products | 1 | 2019 | 166 | 0.140 |
Why?
| Butyrates | 1 | 2017 | 55 | 0.140 |
Why?
| Case-Control Studies | 2 | 2022 | 3296 | 0.140 |
Why?
| Interleukin-12 | 1 | 2016 | 111 | 0.140 |
Why?
| Lymphoid Tissue | 2 | 2020 | 66 | 0.140 |
Why?
| Primates | 2 | 2015 | 114 | 0.140 |
Why?
| B7-1 Antigen | 1 | 2016 | 70 | 0.140 |
Why?
| PTEN Phosphohydrolase | 1 | 2017 | 149 | 0.140 |
Why?
| Amino Acid Sequence | 6 | 2016 | 2123 | 0.140 |
Why?
| NIH 3T3 Cells | 1 | 2016 | 141 | 0.140 |
Why?
| Gene Products, nef | 2 | 2006 | 12 | 0.140 |
Why?
| Antibody Diversity | 1 | 2015 | 17 | 0.130 |
Why?
| Phenotype | 2 | 2016 | 3070 | 0.130 |
Why?
| Histones | 1 | 2020 | 562 | 0.130 |
Why?
| Major Histocompatibility Complex | 1 | 2016 | 224 | 0.130 |
Why?
| Neoplasms | 2 | 2022 | 2235 | 0.130 |
Why?
| Colobus | 1 | 2014 | 3 | 0.130 |
Why?
| Toll-Like Receptor 3 | 1 | 2014 | 32 | 0.130 |
Why?
| Cell Proliferation | 2 | 2019 | 2328 | 0.130 |
Why?
| Endocytosis | 1 | 2016 | 158 | 0.130 |
Why?
| Bacteria | 2 | 2022 | 772 | 0.130 |
Why?
| T-Lymphocytes, Regulatory | 1 | 2017 | 367 | 0.120 |
Why?
| Germinal Center | 1 | 2014 | 49 | 0.120 |
Why?
| Cote d'Ivoire | 2 | 2005 | 9 | 0.120 |
Why?
| Prevalence | 4 | 2006 | 2442 | 0.120 |
Why?
| Papillomaviridae | 1 | 2014 | 102 | 0.120 |
Why?
| Autoimmunity | 1 | 2020 | 852 | 0.120 |
Why?
| Cloning, Molecular | 3 | 2013 | 551 | 0.120 |
Why?
| env Gene Products, Human Immunodeficiency Virus | 1 | 2013 | 16 | 0.120 |
Why?
| Biological Evolution | 2 | 2012 | 457 | 0.120 |
Why?
| Gene Frequency | 1 | 2015 | 522 | 0.120 |
Why?
| Virus Integration | 1 | 2013 | 71 | 0.120 |
Why?
| Immunization | 2 | 2020 | 421 | 0.120 |
Why?
| T-Lymphocyte Subsets | 1 | 2016 | 409 | 0.110 |
Why?
| DNA Damage | 1 | 2015 | 368 | 0.110 |
Why?
| Tanzania | 2 | 2003 | 47 | 0.110 |
Why?
| Amino Acids | 1 | 2016 | 463 | 0.110 |
Why?
| Uganda | 2 | 2003 | 76 | 0.110 |
Why?
| Urine | 2 | 2003 | 65 | 0.110 |
Why?
| Inbreeding | 1 | 2012 | 17 | 0.110 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 459 | 0.110 |
Why?
| Cell Membrane | 1 | 2016 | 741 | 0.100 |
Why?
| Neutralization Tests | 2 | 2008 | 66 | 0.100 |
Why?
| HEK293 Cells | 3 | 2019 | 651 | 0.100 |
Why?
| Adult | 9 | 2020 | 32385 | 0.100 |
Why?
| Down-Regulation | 3 | 2018 | 654 | 0.100 |
Why?
| Mice, Inbred Strains | 1 | 2012 | 418 | 0.100 |
Why?
| Philippines | 3 | 2001 | 56 | 0.100 |
Why?
| Young Adult | 4 | 2020 | 11094 | 0.100 |
Why?
| B-Cell Activation Factor Receptor | 1 | 2010 | 13 | 0.100 |
Why?
| DNA Primers | 3 | 2013 | 540 | 0.100 |
Why?
| vif Gene Products, Human Immunodeficiency Virus | 1 | 2010 | 4 | 0.100 |
Why?
| Middle Aged | 7 | 2020 | 28563 | 0.100 |
Why?
| CD4 Antigens | 3 | 2006 | 136 | 0.100 |
Why?
| Leukemia Virus, Murine | 1 | 2010 | 16 | 0.100 |
Why?
| Phenylacetates | 1 | 2010 | 10 | 0.100 |
Why?
| Cytosine Deaminase | 1 | 2010 | 14 | 0.090 |
Why?
| Gene Products, gag | 1 | 2010 | 37 | 0.090 |
Why?
| Nitrophenols | 1 | 2010 | 35 | 0.090 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 839 | 0.090 |
Why?
| Leukocytes, Mononuclear | 3 | 2022 | 514 | 0.090 |
Why?
| Gene Expression Regulation | 3 | 2018 | 2491 | 0.090 |
Why?
| Plasma | 1 | 2011 | 223 | 0.090 |
Why?
| Escherichia coli | 1 | 2014 | 767 | 0.090 |
Why?
| Lentivirus | 2 | 2013 | 52 | 0.090 |
Why?
| T-Lymphocytes | 3 | 2020 | 1814 | 0.090 |
Why?
| Sequence Analysis, RNA | 1 | 2011 | 420 | 0.090 |
Why?
| Simian foamy virus | 1 | 2008 | 2 | 0.080 |
Why?
| Molecular Epidemiology | 2 | 2006 | 71 | 0.080 |
Why?
| Apoptosis | 3 | 2014 | 2532 | 0.080 |
Why?
| Sequence Homology, Amino Acid | 3 | 2011 | 376 | 0.080 |
Why?
| Receptors, Antigen, B-Cell | 2 | 2020 | 215 | 0.080 |
Why?
| Immunotherapy | 2 | 2023 | 504 | 0.080 |
Why?
| Chromosome Mapping | 1 | 2008 | 518 | 0.080 |
Why?
| Inflammation | 1 | 2018 | 2598 | 0.070 |
Why?
| Mutation | 2 | 2014 | 3493 | 0.070 |
Why?
| Cross-Sectional Studies | 4 | 2018 | 4734 | 0.070 |
Why?
| Promoter Regions, Genetic | 1 | 2011 | 1188 | 0.070 |
Why?
| Lentiviruses, Primate | 1 | 2006 | 13 | 0.070 |
Why?
| Genes, env | 1 | 2005 | 5 | 0.070 |
Why?
| Genes, gag | 1 | 2005 | 3 | 0.070 |
Why?
| Social Dominance | 1 | 2005 | 18 | 0.070 |
Why?
| Blotting, Western | 3 | 2010 | 1225 | 0.070 |
Why?
| Disease Transmission, Infectious | 1 | 2005 | 59 | 0.070 |
Why?
| RNA, Messenger | 2 | 2022 | 2720 | 0.060 |
Why?
| Poliovirus Vaccine, Oral | 1 | 2004 | 19 | 0.060 |
Why?
| Dependovirus | 2 | 2016 | 52 | 0.060 |
Why?
| Infectious Disease Transmission, Vertical | 1 | 2005 | 159 | 0.060 |
Why?
| Cell Survival | 2 | 2019 | 1075 | 0.060 |
Why?
| Endemic Diseases | 1 | 2003 | 29 | 0.060 |
Why?
| Retroviridae Proteins | 1 | 2003 | 12 | 0.060 |
Why?
| Disease Outbreaks | 1 | 2006 | 333 | 0.060 |
Why?
| Time Factors | 1 | 2014 | 6682 | 0.060 |
Why?
| Mice, Transgenic | 2 | 2020 | 2079 | 0.060 |
Why?
| Recombinant Proteins | 2 | 2018 | 1318 | 0.060 |
Why?
| Serine-Arginine Splicing Factors | 1 | 2022 | 21 | 0.060 |
Why?
| Cytidine | 1 | 2022 | 3 | 0.060 |
Why?
| APOBEC Deaminases | 1 | 2022 | 4 | 0.060 |
Why?
| Acquired Immunodeficiency Syndrome | 1 | 2004 | 222 | 0.050 |
Why?
| Apolipoproteins | 1 | 2022 | 40 | 0.050 |
Why?
| Polymerase Chain Reaction | 2 | 2002 | 1021 | 0.050 |
Why?
| Wuchereria bancrofti | 1 | 2001 | 2 | 0.050 |
Why?
| Filariasis | 1 | 2001 | 4 | 0.050 |
Why?
| DNA, Helminth | 1 | 2001 | 16 | 0.050 |
Why?
| Datasets as Topic | 1 | 2022 | 110 | 0.050 |
Why?
| Protein Structure, Tertiary | 2 | 2014 | 832 | 0.050 |
Why?
| World Health Organization | 1 | 2022 | 115 | 0.050 |
Why?
| Macrophages | 2 | 2018 | 1334 | 0.050 |
Why?
| Immunoblotting | 1 | 2002 | 318 | 0.050 |
Why?
| Lymphocyte Depletion | 1 | 2021 | 127 | 0.050 |
Why?
| Hemagglutination | 1 | 2020 | 7 | 0.050 |
Why?
| Carcinogenesis | 1 | 2022 | 184 | 0.050 |
Why?
| Antibodies | 1 | 2022 | 400 | 0.050 |
Why?
| COS Cells | 1 | 2020 | 187 | 0.050 |
Why?
| Immune Evasion | 1 | 2020 | 48 | 0.050 |
Why?
| Snails | 1 | 1999 | 39 | 0.040 |
Why?
| Toll-Like Receptors | 1 | 2020 | 169 | 0.040 |
Why?
| Gene Library | 1 | 1999 | 128 | 0.040 |
Why?
| Erythroblasts | 1 | 2018 | 12 | 0.040 |
Why?
| CD4 Lymphocyte Count | 2 | 2014 | 274 | 0.040 |
Why?
| Recombinant Fusion Proteins | 2 | 2016 | 661 | 0.040 |
Why?
| Nucleic Acid Heteroduplexes | 1 | 1998 | 8 | 0.040 |
Why?
| Interferon Regulatory Factor-7 | 1 | 2018 | 4 | 0.040 |
Why?
| Sex Work | 1 | 1998 | 18 | 0.040 |
Why?
| Sendai virus | 1 | 2018 | 15 | 0.040 |
Why?
| NF-KappaB Inhibitor alpha | 1 | 2018 | 52 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2003 | 1855 | 0.040 |
Why?
| THP-1 Cells | 1 | 2018 | 24 | 0.040 |
Why?
| Rabbits | 1 | 1999 | 808 | 0.040 |
Why?
| Protein Isoforms | 1 | 2019 | 347 | 0.040 |
Why?
| Inpatients | 1 | 2022 | 402 | 0.040 |
Why?
| Disease Progression | 2 | 2016 | 2546 | 0.040 |
Why?
| I-kappa B Kinase | 1 | 2018 | 50 | 0.040 |
Why?
| Enzyme Stability | 1 | 2018 | 77 | 0.040 |
Why?
| Cell Line, Transformed | 1 | 2018 | 140 | 0.040 |
Why?
| Antigenic Variation | 1 | 1997 | 9 | 0.040 |
Why?
| Antigens, Protozoan | 1 | 1997 | 19 | 0.040 |
Why?
| Palatine Tonsil | 1 | 2017 | 32 | 0.040 |
Why?
| Autoantigens | 1 | 2020 | 407 | 0.040 |
Why?
| Anti-Retroviral Agents | 1 | 2019 | 208 | 0.040 |
Why?
| Cross Reactions | 1 | 2017 | 118 | 0.040 |
Why?
| Plasmodium falciparum | 1 | 1997 | 34 | 0.040 |
Why?
| Gene Silencing | 1 | 2018 | 178 | 0.040 |
Why?
| Malaria, Falciparum | 1 | 1997 | 31 | 0.040 |
Why?
| HIV Envelope Protein gp120 | 1 | 2017 | 64 | 0.040 |
Why?
| Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2017 | 40 | 0.040 |
Why?
| Ki-67 Antigen | 1 | 2017 | 114 | 0.040 |
Why?
| DNA, Ribosomal | 1 | 2017 | 82 | 0.040 |
Why?
| Antigens, Surface | 1 | 1997 | 166 | 0.040 |
Why?
| Protozoan Proteins | 1 | 1997 | 68 | 0.040 |
Why?
| Receptors, CXCR4 | 1 | 2017 | 85 | 0.040 |
Why?
| APOBEC-3G Deaminase | 1 | 2016 | 6 | 0.040 |
Why?
| Myxovirus Resistance Proteins | 1 | 2016 | 8 | 0.040 |
Why?
| Peptides | 1 | 2022 | 893 | 0.040 |
Why?
| Interleukin-1beta | 1 | 2019 | 383 | 0.040 |
Why?
| Models, Biological | 1 | 2004 | 1756 | 0.040 |
Why?
| Myeloid Differentiation Factor 88 | 1 | 2016 | 99 | 0.040 |
Why?
| Sequence Deletion | 1 | 2016 | 175 | 0.030 |
Why?
| Amino Acid Motifs | 1 | 2016 | 206 | 0.030 |
Why?
| DNA, Mitochondrial | 2 | 2008 | 189 | 0.030 |
Why?
| DNA, Bacterial | 1 | 2017 | 324 | 0.030 |
Why?
| Protein Processing, Post-Translational | 1 | 2018 | 421 | 0.030 |
Why?
| Imidazoles | 1 | 2016 | 234 | 0.030 |
Why?
| Cluster Analysis | 1 | 2017 | 493 | 0.030 |
Why?
| Receptors, CXCR5 | 1 | 2014 | 11 | 0.030 |
Why?
| Receptors, CCR7 | 1 | 2014 | 25 | 0.030 |
Why?
| Protein Transport | 1 | 2016 | 418 | 0.030 |
Why?
| Cervix Uteri | 1 | 2014 | 48 | 0.030 |
Why?
| Biopsy | 1 | 2018 | 1090 | 0.030 |
Why?
| RNA, Ribosomal, 16S | 1 | 2017 | 535 | 0.030 |
Why?
| Viral Proteins | 1 | 2016 | 300 | 0.030 |
Why?
| Sexual Behavior | 1 | 1998 | 470 | 0.030 |
Why?
| Antigens, Viral | 1 | 2014 | 181 | 0.030 |
Why?
| Antibodies, Monoclonal | 1 | 2020 | 1306 | 0.030 |
Why?
| Vaccines | 1 | 1999 | 384 | 0.030 |
Why?
| Caspase 1 | 1 | 2014 | 143 | 0.030 |
Why?
| Phosphorylation | 1 | 2018 | 1733 | 0.030 |
Why?
| Genetic Engineering | 1 | 2013 | 84 | 0.030 |
Why?
| Mucous Membrane | 1 | 2014 | 120 | 0.030 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 294 | 0.030 |
Why?
| Sequence Alignment | 1 | 2013 | 343 | 0.030 |
Why?
| In Vitro Techniques | 1 | 2014 | 1130 | 0.030 |
Why?
| Retroelements | 1 | 2011 | 34 | 0.030 |
Why?
| Cytokines | 1 | 2019 | 1928 | 0.030 |
Why?
| HIV Reverse Transcriptase | 1 | 2010 | 28 | 0.020 |
Why?
| Glycosylation | 1 | 2010 | 134 | 0.020 |
Why?
| Cell Movement | 1 | 2014 | 929 | 0.020 |
Why?
| Aged | 2 | 2017 | 20495 | 0.020 |
Why?
| HIV Core Protein p24 | 1 | 2009 | 28 | 0.020 |
Why?
| L-Selectin | 1 | 2009 | 27 | 0.020 |
Why?
| Autoantibodies | 1 | 2017 | 1353 | 0.020 |
Why?
| Microbiota | 1 | 2017 | 676 | 0.020 |
Why?
| DNA Replication | 1 | 2010 | 214 | 0.020 |
Why?
| Child | 2 | 2017 | 19561 | 0.020 |
Why?
| Africa, Central | 1 | 2008 | 3 | 0.020 |
Why?
| Alternative Splicing | 1 | 2010 | 197 | 0.020 |
Why?
| Genetics, Microbial | 1 | 2008 | 9 | 0.020 |
Why?
| Infant, Newborn | 1 | 1999 | 5430 | 0.020 |
Why?
| HLA-DR Antigens | 1 | 2009 | 228 | 0.020 |
Why?
| Aged, 80 and over | 1 | 1999 | 6845 | 0.020 |
Why?
| Adolescent | 2 | 2012 | 18948 | 0.020 |
Why?
| Gene Products, pol | 1 | 2007 | 6 | 0.020 |
Why?
| Ecology | 1 | 2008 | 109 | 0.020 |
Why?
| Consensus Sequence | 1 | 2007 | 70 | 0.020 |
Why?
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2006 | 8 | 0.020 |
Why?
| Cameroon | 1 | 2006 | 10 | 0.020 |
Why?
| Prospective Studies | 1 | 1998 | 6704 | 0.020 |
Why?
| HIV Antibodies | 1 | 2006 | 50 | 0.020 |
Why?
| Infant | 1 | 1999 | 8523 | 0.020 |
Why?
| Child, Preschool | 1 | 1999 | 9755 | 0.020 |
Why?
| p21-Activated Kinases | 1 | 2004 | 14 | 0.020 |
Why?
| CD28 Antigens | 1 | 2004 | 48 | 0.020 |
Why?
| Africa, Western | 1 | 2004 | 17 | 0.020 |
Why?
| Protein Binding | 1 | 2010 | 2010 | 0.020 |
Why?
| Haplotypes | 1 | 2006 | 482 | 0.020 |
Why?
| Risk Factors | 1 | 1998 | 9381 | 0.020 |
Why?
| Mutagenesis, Site-Directed | 1 | 2005 | 368 | 0.020 |
Why?
| HeLa Cells | 1 | 2005 | 609 | 0.010 |
Why?
| Green Fluorescent Proteins | 1 | 2005 | 402 | 0.010 |
Why?
| Ecosystem | 1 | 2008 | 579 | 0.010 |
Why?
| Transfection | 1 | 2005 | 909 | 0.010 |
Why?
| Histocompatibility Antigens Class II | 1 | 2004 | 397 | 0.010 |
Why?
| Deoxyribonucleases, Type II Site-Specific | 1 | 2001 | 17 | 0.010 |
Why?
| Africa | 1 | 2001 | 102 | 0.010 |
Why?
| Malaria Vaccines | 1 | 1997 | 6 | 0.010 |
Why?
| DNA, Protozoan | 1 | 1997 | 28 | 0.010 |
Why?
| Point Mutation | 1 | 1997 | 231 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2004 | 2977 | 0.010 |
Why?
| Epitopes | 1 | 1997 | 450 | 0.010 |
Why?
|
|
Santiago's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|